{
    "clinical_study": {
        "@rank": "149733", 
        "acronym": "DMBSS", 
        "arm_group": [
            {
                "arm_group_label": "LRYGB", 
                "arm_group_type": "Active Comparator", 
                "description": "20 subjects Randomized will undergo LRYGB surgery"
            }, 
            {
                "arm_group_label": "SADJB", 
                "arm_group_type": "Active Comparator", 
                "description": "20 subjects will undergo SADJB surgery"
            }, 
            {
                "arm_group_label": "LMGB", 
                "arm_group_type": "Active Comparator", 
                "description": "20 subjects will undergo LMGB surgery"
            }
        ], 
        "brief_summary": {
            "textblock": "The investigators would like to conduct a randomized clinical trial to compare the efficacy\n      of diabetes treatment between different gastric bypass procedures involving type 2 diabetics\n      patients with BMI from 27.5 to 35 kg/m2"
        }, 
        "brief_title": "DMBSS-A Randomized Trial of Different Laparoscopic Gastric Bypass Surgery in Patients With Obesity-related T2DM", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Diabetes Mellitus Type 2 in Obese", 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 2", 
                "Obesity"
            ]
        }, 
        "detailed_description": {
            "textblock": "The investigators would like to conduct a randomized clinical trial to compare the efficacy\n      of diabetes treatment between different gastric bypass procedures involving type 2 diabetics\n      patients with BMI from 27.5 to 35 kg/m2. This program will determine the relative\n      effectiveness among LMGB \u3001RYGB and SADJB .The primary end point including HbA1C<6.0%,\n      LDL-C<100mg/dl and SBP<130mmHg at one year after surgery. Through this study, the\n      investigators may understand which gastric bypass is the best for type 2 diabetic's\n      treatment. The investigators also hope some new treatment modulation may be developed."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age 20 to 67 years\n\n          -  Diagnosed with T2DM at least 6 months prior to enrollment, under the active care of a\n             doctor for at least the six months prior to enrollment, HbA1c \u2265 7.5 %\n\n          -  Body Mass Index (BMI) \u2265 27.5 kg/m 2  and \u2264 34.9 kg/m 2\n\n          -  Willingness to accept random assignment to either treatment group.\n\n          -  Willingness to comply with the follow-up protocol\n\n          -  Written informed consent.\n\n        Exclusion Criteria:\n\n          -  Cardiovascular event (myocardial infarction, acute coronary syndrome, coronary artery\n             angioplasty or bypass, stroke) in the past six months.\n\n          -  Current evidence of congestive heart failure, angina pectoris, or symptomatic\n             peripheral vascular disease.\n\n          -  Cardiac stress test indicating that surgery would not be safe.\n\n          -  Pulmonary embolus or thrombophlebitis in the past six months\n\n          -  Cancer of any kind (except basal cell skin cancer or cancer in situ) unless\n             documented to be disease-free for five years\n\n          -  Serum creatinine \u2265 1.5 mg/dl\n\n          -  History of stomach surgery, bile duct surgery, pancreatic surgery, splenectomy, or\n             colon resection\n\n          -  Previous organ transplantation.\n\n          -  History of alcohol or drug dependency\n\n          -  Current participation in a conflicting research protocol."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "67 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 22, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01989988", 
            "org_study_id": "MSIRB2013003", 
            "secondary_id": "MSIRB2013003"
        }, 
        "intervention": [
            {
                "arm_group_label": "LMGB", 
                "intervention_name": "LMGB", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "LRYGB", 
                "intervention_name": "LRYGB", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "SADJB", 
                "intervention_name": "SADJB", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Type 2 Diabetes Mellitus (T2DM)", 
            "Obesity", 
            "Laparoscopic gastric bypass", 
            "Duodenum exclusion"
        ], 
        "lastchanged_date": "November 15, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Taoyuan City", 
                    "country": "Taiwan", 
                    "zip": "330"
                }, 
                "name": "Min-Sheng General Hospital"
            }
        }, 
        "location_countries": {
            "country": "Taiwan"
        }, 
        "number_of_arms": "3", 
        "official_title": "A Randomized Trial Study of Different Laparoscopic Gastric Bypass Surgery in Patients With Obesity-related T2DM", 
        "overall_official": {
            "affiliation": "Min-Sheng General Hospital", 
            "last_name": "Wei-Jei Lee, M.D., PH.D", 
            "role": "Study Chair"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Taiwan: Department of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "remission of Diabetes Mellitus Type 2 after different types of Gastric bypass surgery", 
            "measure": "Remission of diabetes", 
            "safety_issue": "Yes", 
            "time_frame": "two years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01989988"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Min-Sheng General Hospital", 
            "investigator_full_name": "WEI-CHENG YAO", 
            "investigator_title": "Department of Surgery", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "weight loss and improvements in quality of life after different types of gastric bypass surgery", 
            "measure": "weight loss and improvement in quality of life", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "source": "Min-Sheng General Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Min-Sheng General Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}